<track id="d3tj5"></track>
      <track id="d3tj5"></track>
      <li id="d3tj5"></li>
      <progress id="d3tj5"></progress>
      <dfn id="d3tj5"></dfn>
        <bdo id="d3tj5"></bdo>


              Abcam news

              May-2019

              New tissue clearing kits and reagents for faster, accurate 3D imaging

              Apr-2019

              NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler

              Mar-2019

              Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging

              Mar-2019

              Abcam wins the UK-China Business award

              Feb-2019

              Abcam moves to new purpose-built global headquarters

              Feb-2019

              Dr Michael Weiner wins CiteAb’s 2019 Lifetime achievement award

              Jan-2019

              Abcam expands custom services capabilities with the acquisition of Calico Biolabs

              Jan-2019

              Abcam and the LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder

              Dec-2018

              QIAGEN (Suzhou) and Abcam sign strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market

              Dec-2018

              Abcam 'Most Admired Company' award

              Oct-2018

              Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development

              Oct-2018

              New PBS-only antibodies enable more flexible research

              Jul-2018

              Abcam Merck collaboration produces new PD-L1 antibody for immuno-oncology research

              Jun-2018

              Congratulations to Alan Hirzel, winner of European Mediscience Awards Chief Executive of the year award

              Apr-2018

              Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development

              Feb-2018

              New CatchPoint? SimpleStep? ELISA fluorescent 90-minute assay

              Feb-2018

              Introducing FirePlex?-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples

              Feb-2018

              Abcam and Molecular Devices announce strategic collaboration

              Jan-2018

              Abcam wins another CiteAb award

              Jan-2018

              Abcam signs exclusive license agreement with Roche

              Aug-2017

              Abcam and TTP Labtech collaborate to develop sol-R reagent kits

              Jul-2017

              The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins

              Jun-2017

              Abcam announces first international Epigenetics conference in South Korea

              Jan-2017

              Abcam wins two CiteAb awards

              Nov-2016

              Abcam wins Best Careers Website at the In-house Recruitment Awards

              Jul-2016

              New multiplex immunoassays with Firefly? particle technology

              Apr-2016

              Abcam enables faster drug and biomarker discovery with immunoassay research suite

              Feb-2016

              Congratulations to Jonathan Milner, winner of CiteAb’s Lifetime achievement award

              Nov-2015

              Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers

              Nov-2015

              Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership

              Oct-2015

              Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research

              Sep-2015

              Abcam raises antibody validation standards to improve quality for life science researchers

              Jun-2015

              Appointment of Chief Legal Officer and Company Secretary

              Jun-2015

              Abcam launches multiplex miRNA profiling assays

              Jan-2015

              Abcam signs exclusive partnership agreement with A*STAR's Institute of Molecular and Cell Biology

              Dec-2014

              Sue Harris appointed as non-Executive Director on Abcam Board

              Dec-2014

              Abcam appoints Yvonne Chien as Chief Digital Officer

              Nov-2014

              Abcam wins 'Best Use of Digital Media' at Life Science Industry Awards

              Sep-2014

              Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute

              Sep-2014

              Abcam plc announces appointment of new CEO and Board changes

              Sep-2014

              Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb? antibodies

              Sep-2014

              Abcam introduces exclusive range of highly validated antibody conjugates

              Aug-2014

              Abcam establishes new direct service for Australia and New Zealand

              Jun-2014

              Abcam's CEO wins Mediscience award

              Mar-2014

              Abcam introduces Alexa Fluor? 680/790 secondary antibodies for fluorescent western blotting

              Feb-2014

              Abcam Announces Winner of 15 Discoveries Contest

              Jan-2014

              Abcam to open office in Shanghai, China

              Dec-2013

              Abcam wins 'Most Admired Company' award

              Nov-2013

              Abcam Introduces Alexa Fluor Secondary Antibodies

              Oct-2013

              Abcam Named AIM Company of the Year

              Sep-2013

              Abcam Launches SimpleStep ELISA Kits

              Jun-2013

              Abcam appoints Alan Hirzel as Chief Marketing Officer

              Apr-2013

              Abcam Welcomes Students from Cambridge Regional College

              Mar-2013

              Abcam donates an additional £45,000 to local charities

              Dec-2012

              Abcam helps contribute to growth of hi-tech sector in Cambridge, UK

              Nov-2012

              We have reached 100,000 products

              Oct-2012

              HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action

              Sep-2012

              Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics

              Jan-2012

              New range of Biochemicals now available from Abcam

              Sep-2011

              Abcam acquires Ascent Scientific, a specialist provider of biochemicals

              May-2011

              Abcam acquires MitoSciences in deal which enhances immunoassay portfolio

              Nov-2010

              Jonathan Milner wins Entrepreneur of the Year award.

              Jul-2010

              Abcam's Jonathan Milner wins CEO of the Year

              Jul-2010

              300th employee hired

              Mar-2010

              Abcam wins 'Business of the Year 2009' at the Business Weekly East of England Awards.

              Feb-2010

              Abcam founder wins 'CEO of the Year' at Quoted Company Awards 2010

              Jan-2010

              Abcam and Cambridge Design Partnership develop innovative labeling solution

              Oct-2009

              Abcam named 'Company of the Year' at 2009 AIM Awards

              Jun-2009

              Abcam’s expansion continues with its fourth move on the Cambridge Science Park

              Nov-2008

              Winners of tenth anniversary competition announced

              Jul-2008

              200th employee hired

              May-2008

              Licensing deal signed with Tepnel Life Sciences

              Mar-2008

              Grand setting for Japanese sub-dealer meetings

              Nov-2007

              Automated system to expand monoclonal production

              Nov-2007

              Abcam and leading antibody producer collaborate to make 12,000 rabbit polyclonals

              Nov-2007

              CLC bio customized software supports Abcam's monoclonal development capability

              Nov-2007

              Jeffrey Iliffe appointed as Chief Financial Officer

              May-2007

              Same day delivery in Cambridge UK

              Mar-2007

              Over 30,000 products in our catalog

              Mar-2007

              Abcam to partner in the EPITRON project

              Jan-2007

              $2 to Médecins Sans Frontières for every new registration

              Jul-2006

              Extra Abpoints introduced for first Abreviews

              Jul-2006

              Appointment of Non-Executive Directors

              Jun-2006

              Winner of Best Newcomer in the UK techMARK mediscience awards

              May-2006

              Better antibodies, faster

              Feb-2006

              Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005

              Feb-2006

              20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news

              Jan-2006

              Fast Abpromise support, free loading control samples, Abupdate & news

              Nov-2005

              Search filter, conjugated loading controls, Abupdate & news

              Oct-2005

              Extended North America customer service hours

              Sep-2005

              Top forty position, Sunday Times Microsoft Tech Track

              May-2005

              US office on the move

              Apr-2005

              Queen's Award at first attempt

              Apr-2005

              More space

              Dec-2004

              A faster service

              Oct-2004

              First place in Deloitte's Fast 50

              Sep-2004

              50th employee hired

              Sep-2004

              Top forty position, Sunday Times Microsoft Tech Track

              Jun-2004

              Jim Warwick becomes Managing Director (Abcam Ltd)

              Feb-2004

              Collaboration deal struck with Purely Proteins

              Jan-2004

              A New Year's Honour

              Dec-2003

              High growth status recognised again, this time nationally

              Oct-2003

              Success in Deloitte's Regional Technology Fast 50

              Sep-2003

              Top twenty position, Sunday Times Arm Tech Track

              Jul-2003

              British royalty visits Abcam

              May-2003

              First overseas office established

              Apr-2003

              Jim Warwick (Technical Director) becomes full-time

              Mar-2003

              CEN Business Excellence Awards winner

              Mar-2003

              25th employee hired

              Feb-2003

              On the move again

              Nov-2002

              Deloitte Top 50 regional winner

              Aug-2002

              FedEx tie-up boosts customer support services

              Jun-2001

              Technical Director appointed

              May-2001

              UK Online for Business Award, highly commended

              Oct-2000

              CEN Millennium Business Excellence Awards finalist

              May-2000

              10th employee hired

              Apr-2000

              Finance Director appointed

              Mar-2000

              New premises on the Cambridge Science Park

              Oct-1999

              First (of many) awards

              Oct-1998

              Open for business

              注冊
              狼人干,狼人干综合,情色综合,狼人干综合伊人网